MEIP Overview

Corporate Rebranding: MEI Pharma, Inc. will rebrand as Lite Strategy, Inc. and change its NASDAQ ticker from MEIP to LITS, reflecting its focus on digital asset treasury management, particularly with Litecoin (LTC) as a primary reserve asset.

Strategic Partnerships: The company is collaborating with GSR Ventures for liquidity and risk management in its LTC treasury strategy, while also continuing to explore new drug development opportunities.

Robinhood's Market Movement: Robinhood Markets, Inc. shares surged 7.4% in pre-market trading after being announced as a replacement for Caesars Entertainment in the S&P 500, effective September 22.

Other Notable Gainers: Several stocks saw significant pre-market gains, including Eightco Holdings (up 142.1%), Gyrodyne (up 82.1%), and Forward Industries (up 78.8%).

Pre-Market Losers: Citius Oncology experienced a 25% drop, while MEI Pharma and CNFinance also saw declines of 19.3% and 18.8%, respectively, in pre-market trading.

Market Overview: The article provides a snapshot of various stocks' performances, highlighting both significant gainers and losers in the pre-market trading session.

MEI Pharma's Acquisition: MEI Pharma has become the first U.S.-listed public company to adopt Litecoin as its primary treasury reserve asset, acquiring 929,548 LTC tokens valued at approximately $110.4 million as part of a $100 million institutional treasury strategy in collaboration with crypto market maker GSR and Litecoin creator Charlie Lee.

Reasons for Choosing Litecoin: The decision to adopt Litecoin is based on its reliability, low fees, fast settlements, and existing ecosystem adoption through platforms like PayPal and Venmo, marking a significant shift towards fintech while maintaining focus on its drug development pipeline.

U.S. Stock Market Update: U.S. stock futures showed positive movement on Monday following a mixed performance last Friday, with major indices like the Dow Jones and S&P 500 experiencing slight declines while the Nasdaq Composite rose. Investors are anticipating significant earnings reports from companies such as Tesla and Alphabet this week.

Economic Indicators and Fed Outlook: The Commerce Secretary emphasized August 1 as a deadline for tariffs but indicated willingness to negotiate beyond that date. Additionally, economic data revealed a rise in consumer sentiment and stable inflation expectations, leading analysts to suggest a high likelihood of the Federal Reserve maintaining current interest rates in its upcoming meeting.

MEI Pharma's Investment and Stock Performance: MEI Pharma, Inc. is experiencing a surge in stock price, trading at $5.92 after a 31.54% increase, following a private investment deal that raised approximately $100 million through the sale of 29.2 million shares at $3.42 each.

Adoption of Litecoin as Treasury Asset: The company has become the first publicly traded entity to adopt Litecoin as a treasury reserve asset, appointing Charlie Lee to its board and engaging GSR for digital asset management, marking a significant step in its long-term strategic plan.

U.S. Stock Market Performance: U.S. stocks fell, with the Dow Jones dropping over 200 points and sectors like communication services declining, while utilities saw a rise of 1.9%.

Company Highlights: 3M reported strong second-quarter results and raised its full-year guidance, while Telomir Pharmaceuticals and MEI Pharma experienced significant stock surges due to positive announcements, contrasting with sharp declines in LQR House Inc. and Northern Dynasty Minerals Ltd.